Click here to read the story of Laurie and his family.
Our globally-focused “Science Portfolio”, the single largest dystonia research program in North America, led by a committee of movement disorder specialists, is focused on contracting with researchers on specific projects, engaging the biotech industry and providing opportunities for the next generation of experts.
The DMRF Canada receives no government funding. As dystonia is a disease that is still a mystery in many ways, and sadly, still not very well known to the general population, we are reliant on individual donors and foundations that understand the devastating impact of this disorder and understand that our best way forward is to continue to invest in research that will lead us to a cure.
Current DMRF dystonia research is focused on turning meaningful laboratory discoveries into practical applications that improve the lives of persons with the disorder.
Here are the Latest Dystonia Research Findings, funded by DMRF
DYT6 Dystonia Protein Regulates Process Critical for Neuron Maturation
DMRF-Funded Investigators Evaluate AZD1446 as Possible Dystonia Drug
Dystonia Research at Work
Since our inception, DMRF has contributed over $10 million into dystonia related research projects. Because of these investments, our understanding of dystonia has changed dramatically. Today we know that complex communication between several different areas of the brain is responsible for controlling movement. To date, 23 dystonia (DYT) genes and gene markers have been identified. DMRF’s work has inspired investigators around the world to collaboratively explore opportunities for new treatments and to find a cure.